Hangzhou Tigermed Consulting Co Liabilities 2024

Hangzhou Tigermed Consulting Co Aktienanalyse

What does Hangzhou Tigermed Consulting Co do?

Hangzhou Tigermed Consulting Co Ltd is a leading Chinese company in the field of clinical research and medical services. The company was founded in Hangzhou in 2004 and has since experienced rapid development. Today, the company has branches in over 20 countries and employs over 11,000 people worldwide. Hangzhou Tigermed's business model is based on supporting the entire value chain of clinical trials, from planning and execution to statistical analysis and data interpretation. The company works closely with global actors from the pharmaceutical industry, biomedical research institutions, and regulatory authorities to meet international standards for clinical studies. Over the years, Hangzhou Tigermed has expanded its business activities to include various areas such as data management, biostatistics, medical translation, clinical monitoring, drug safety monitoring, and traceability. An important part of Hangzhou Tigermed's business model is the ability to use high-tech platforms and IT systems to enable real-time monitoring and communication during a clinical trial. This allows the company to quickly respond to adverse events and monitor the progress of the study in real-time. The company also offers specialized services, such as the evaluation of oncology studies and the conduct of studies in the field of traditional Chinese medicine. In addition, Hangzhou Tigermed also has its own pharmaceutical research department specializing in the development of innovative drugs. The company has built strong research and development capabilities, with a focus on open innovation projects and partnerships with research institutions and pharmaceutical companies. In collaboration with its industry partners, Hangzhou Tigermed has conducted a number of research projects that have led to significant innovations in medicine. Hangzhou Tigermed also has a strong presence in the international market, particularly in North America and Europe. Through its branches in these regions, the company is able to offer comprehensive collaboration to its customers on a global level. Overall, Hangzhou Tigermed Consulting Co Ltd has established itself as a significant force in the clinical research industry. The company has developed a wide range of services to meet the needs of its customers in the industry. Hangzhou Tigermed's ability to work closely with its customers and adhere to global standards has helped it become a preferred partner for clinical studies and innovative research projects worldwide. Hangzhou Tigermed Consulting Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Hangzhou Tigermed Consulting Co's Liabilities

Hangzhou Tigermed Consulting Co's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Hangzhou Tigermed Consulting Co's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Hangzhou Tigermed Consulting Co's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Hangzhou Tigermed Consulting Co's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Hangzhou Tigermed Consulting Co’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Hangzhou Tigermed Consulting Co stock

What is the level of liabilities of Hangzhou Tigermed Consulting Co this year?

Hangzhou Tigermed Consulting Co has a debt balance of 8.65 B CNY this year.

What were the liabilities of Hangzhou Tigermed Consulting Co compared to the previous year?

The liabilities of Hangzhou Tigermed Consulting Co have increased by 10.05% increased compared to the previous year.

What are the consequences of high debt for investors of Hangzhou Tigermed Consulting Co?

High liabilities can pose a risk for investors of Hangzhou Tigermed Consulting Co, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Hangzhou Tigermed Consulting Co?

Low liabilities mean that Hangzhou Tigermed Consulting Co has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Hangzhou Tigermed Consulting Co affect the company?

An increase in liabilities of Hangzhou Tigermed Consulting Co can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Hangzhou Tigermed Consulting Co affect the company?

A decrease in the liabilities of Hangzhou Tigermed Consulting Co can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Hangzhou Tigermed Consulting Co?

Some factors that can influence the liabilities of Hangzhou Tigermed Consulting Co include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Hangzhou Tigermed Consulting Co so important for investors?

The liabilities of Hangzhou Tigermed Consulting Co are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Hangzhou Tigermed Consulting Co take to modify the liabilities?

To change its liabilities, Hangzhou Tigermed Consulting Co can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Hangzhou Tigermed Consulting Co pay?

Over the past 12 months, Hangzhou Tigermed Consulting Co paid a dividend of 0.55 CNY . This corresponds to a dividend yield of about 1.05 %. For the coming 12 months, Hangzhou Tigermed Consulting Co is expected to pay a dividend of 0.6 CNY.

What is the dividend yield of Hangzhou Tigermed Consulting Co?

The current dividend yield of Hangzhou Tigermed Consulting Co is 1.05 %.

When does Hangzhou Tigermed Consulting Co pay dividends?

Hangzhou Tigermed Consulting Co pays a quarterly dividend. This is distributed in the months of July, June, August, August.

How secure is the dividend of Hangzhou Tigermed Consulting Co?

Hangzhou Tigermed Consulting Co paid dividends every year for the past 14 years.

What is the dividend of Hangzhou Tigermed Consulting Co?

For the upcoming 12 months, dividends amounting to 0.6 CNY are expected. This corresponds to a dividend yield of 1.14 %.

In which sector is Hangzhou Tigermed Consulting Co located?

Hangzhou Tigermed Consulting Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Hangzhou Tigermed Consulting Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Hangzhou Tigermed Consulting Co from 7/12/2024 amounting to 0.568 CNY, you needed to have the stock in your portfolio before the ex-date on 7/12/2024.

When did Hangzhou Tigermed Consulting Co pay the last dividend?

The last dividend was paid out on 7/12/2024.

What was the dividend of Hangzhou Tigermed Consulting Co in the year 2023?

In the year 2023, Hangzhou Tigermed Consulting Co distributed 0.5 CNY as dividends.

In which currency does Hangzhou Tigermed Consulting Co pay out the dividend?

The dividends of Hangzhou Tigermed Consulting Co are distributed in CNY.